Symptoms
Tuberculosis may infect any part of the body, but most commonly occurs in the lungs (known as pulmonary tuberculosis).Extrapulmonary TB occurs when tuberculosis develops outside of the lungs.
General signs and symptoms include fever, chills, night sweats, loss of appetite, weight loss, and fatigue. Significant nail clubbing may also occur.
Pulmonary
If a tuberculosis infection does become active, it most commonly involves the lungs (in about 90% of cases). Symptoms may include chest pain and a prolonged cough producing sputum. About 25% of people may not have any symptoms (i.e. they remain "asymptomatic"). Occasionally, people may cough up blood in small amounts, and in very rare cases, the infection may erode into the pulmonary artery or a Rasmussen's aneurysm, resulting in massive bleeding. Tuberculosis may become a chronic illness and cause extensive scarring in the upper lobes of the lungs. The upper lung lobes are more frequently affected by tuberculosis than the lower ones.
Extrapulmonary
In 15–20% cases, the infection spreads outside the lungs, causing other kinds of TB. These are collectively denoted as "extrapulmonary tuberculosis". Extrapulmonary TB occurs more commonly in immunosuppressed persons and young children. In those with HIV, this occurs in more than 50% of cases. Notable extrapulmonary infection sites include the pleura (in tuberculous pleurisy), the central nervous system (in tuberculous meningitis), the lymphatic system (in scrofula of the neck), the genitourinary system (in urogenital tuberculosis), and the bones and joints (in Pott disease of the spine), among others. When it spreads to the bones, it is also known as "osseous tuberculosis", a form of osteomyelitis. Sometimes, bursting of a tubercular abscess through skin results in tuberculous ulcer. An ulcer originating from nearby infected lymph nodes is painless, slowly enlarging and has an appearance of "wash leather". A potentially more serious, widespread form of TB is called "disseminated tuberculosis", also known as miliary tuberculosis. Miliary TB makes up about 10% of extrapulmonary cases.
- Active phase
- Extrapulmonary
- latent phase
- Pulmonary
Related Conference of Symptoms
9th International Conference on Antimicrobial and Antibacterial Agents
10th International Conference on Microbiome, Probiotics & Gut Nutrition
9th International Conference on Clinical Microbiology, Virology and Infectious Diseases
22nd International Conference on Microbial Interactions & Microbial Ecology
13th International Congress on Trauma, Critical Care and Emergency Medicine
Symptoms Conference Speakers
Recommended Sessions
- : Causes of Tuberculosis
- Challenges in TB diagnostics
- Diagnosis
- Epidemiology of the disease
- Genome
- Intoduction to Tuberculosis
- Mycobacterium tuberculosis infection
- New research and development
- Pathogenesis
- Prevention
- Pulmonary disorders
- Resistance to TB drugs
- Surveillance and Tracking of Drug-Resistant TB
- Symptoms
- TB and HIV co-infection
- TB clinical trials
- Treatment (Vaccines & Immunization)
Related Journals
Are you interested in
- Advances in Bacteriology and Microbiology - Bacteriology-2026 (UAE)
- Agricultural Microbiology & Plant–Microbe Interactions - Beneficial Microbes 2027 (UK)
- Animals in a Bacterial World-A New Imperative for the Life Sciences - Microbiome 2026 (USA)
- Antimicrobial Resistance and Antibiotic Alternatives - Bacteriology-2026 (UAE)
- Arbuscular Mycorrhizal Fungi (AMF) - Microbiome 2026 (USA)
- Bacterial and Microbial Genomics & Proteomics - Bacteriology-2026 (UAE)
- Bacterial Selection for Biological Control of Plant Disease - Microbiome 2026 (USA)
- Biofilms & Microbial Surface Interactions - Beneficial Microbes 2027 (UK)
- Bioinformatics and Microbial Data Science - Bacteriology-2026 (UAE)
- Biostimulants and Biocontrol Strategies - Microbiome 2026 (USA)
- Clinical Microbiology and Infectious Diseases - Bacteriology-2026 (UAE)
- Computational and AI-driven Microbiology - Bacteriology-2026 (UAE)
- Environmental Microbiology and Bioremediation - Bacteriology-2026 (UAE)
- Extremophiles & Microbial Adaptation - Beneficial Microbes 2027 (UK)
- Food Microbiology and Safety - Bacteriology-2026 (UAE)
- Harnessing Phytomicrobiome Signaling for Microbiome Engineering - Microbiome 2026 (USA)
- Industrial Microbiology and Biotechnology - Bacteriology-2026 (UAE)
- Interplay Between Diet, Gut Microbiota, Epigenetic Events and Colorectal Cancer - Microbiome 2026 (USA)
- Marine Microbiology & Microbial Resources - Beneficial Microbes 2027 (UK)
- Medical and Pharmaceutical Microbiology - Bacteriology-2026 (UAE)
- Microbial Biomanufacturing & Bioeconomy - Beneficial Microbes 2027 (UK)
- Microbial Biomaterials & Bio-Based Products - Beneficial Microbes 2027 (UK)
- Microbial Communication & Quorum Sensing - Beneficial Microbes 2027 (UK)
- Microbial Diagnostics & Advanced Detection Technologies - Beneficial Microbes 2027 (UK)
- Microbial Ecology & Community Interactions - Beneficial Microbes 2027 (UK)
- Microbial Ecology and Evolution - Bacteriology-2026 (UAE)
- Microbial Enzymes & Biocatalysis - Beneficial Microbes 2027 (UK)
- Microbial Enzymes and Metabolites - Bacteriology-2026 (UAE)
- Microbial Evolution & Adaptive Biology - Beneficial Microbes 2027 (UK)
- Microbial Fermentation & Bioprocess Development - Beneficial Microbes 2027 (UK)
- Microbial Metabolites & Bioactive Compounds - Beneficial Microbes 2027 (UK)
- Microbial Pathogenesis and Host Interactions - Bacteriology-2026 (UAE)
- Microbial Resources & Culture Collections - Beneficial Microbes 2027 (UK)
- Microbiome and Human Health - Bacteriology-2026 (UAE)
- Microbiome as a Human Organ - Microbiome 2026 (USA)
- Microbiome- Science Comes to Life - Microbiome 2026 (USA)
- Modulation of Microbiota - Microbiome 2026 (USA)
- One Health & Microbial Interactions - Beneficial Microbes 2027 (UK)
- Pediatric Microbiome-Vaginal Delivery vs C-Section - Microbiome 2026 (USA)
- Plant Beneficial Microbes - Microbiome 2026 (USA)
- Plant Conditioners (Biostimulants) - Microbiome 2026 (USA)
- Role of Microbial Communities in Periodontal Diseases and Caries (Oral Microbiome) - Microbiome 2026 (USA)
- Signaling in the PhytoMicrobiome - Microbiome 2026 (USA)
- Skincare Products with Probiotics-Worth the Hype? - Microbiome 2026 (USA)
- Synthetic and Systems Microbiology - Bacteriology-2026 (UAE)
- The Gut Microbiota - Centerpiece of Human Health - Microbiome 2026 (USA)
- The Microbiome as a Therapeutic Target for Metabolic Diseases - Microbiome 2026 (USA)
- The Microbiome in Cancer Development and Therapy - Microbiome 2026 (USA)
- The Microbiota in Early Life Shapes the Immune System - Microbiome 2026 (USA)
- The Skin Microbiome - Microbiome 2026 (USA)
